Tic disorders are characterized by sudden, rapid, and repetitive motor movements or vocalizations. Although they typically begin in childhood, many individuals continue to experience them into adulthood. This persistence can negatively impact social relationships, professional life, and overall psychological well-being. Overlooking adult tic disorders may delay accurate diagnosis and access to treatment. Therefore, understanding the clinical and psychosocial dimensions of adult tic disorders is essential.
Main Discussion
Characteristics and Prevalence of Tics
Tics are generally divided into motor and vocal categories. Simple motor tics include eye blinking or shoulder shrugging, while simple vocal tics may involve throat clearing or coughing. More complex tics may consist of organized movements or the utterance of meaningful words or phrases (Leckman et al., 2013). While many childhood-onset tics tend to improve during adolescence, Robertson (2015) reports that up to one-third of adults continue to experience significant symptoms.
In adults, tics often fluctuate in severity, increasing during periods of stress, fatigue, or anxiety. Many adults also describe a premonitory urge, a physical or psychological tension that is relieved only by performing the tic (Kwak et al., 2003). This feature highlights the involuntary yet compelling nature of tic behaviors.
Psychosocial Impact
Tic disorders are not only neurological conditions but also psychosocial challenges. As Woods et al. (2008) emphasize, adults often face misunderstanding and social stigma due to their tics, which can reduce self-esteem and quality of life. Moreover, comorbid conditions such as anxiety disorders, depression, and obsessive-compulsive disorder frequently accompany tic disorders, further complicating the clinical picture (Hirschtritt et al., 2015).
Treatment Approaches
Treatment of adult tic disorders involves a multifaceted approach. Behavioral therapy interventions are considered the first-line option. The Comprehensive Behavioral Intervention for Tics (CBIT) helps individuals increase awareness of their tics, develop competing responses, and manage triggers. In a randomized controlled trial, Piacentini et al. (2010) demonstrated that CBIT significantly reduced tic severity in both children and adults.
Pharmacological treatments are also widely used. Antipsychotic medications such as risperidone and aripiprazole remain the most common options (Cavanna & Rickards, 2013). In some cases, alpha-2 adrenergic agonists like clonidine may be beneficial. However, the potential side effects of long-term medication use require careful monitoring.
For severe and treatment-resistant cases, neuromodulation techniques such as deep brain stimulation (DBS) are being explored. Martinez-Ramirez et al. (2018) highlight that DBS targeting basal ganglia structures shows promising results in reducing tic severity. Nevertheless, this intervention is still considered experimental and reserved for select cases.
Conclusion
Adult tic disorders, though less commonly discussed, can cause considerable functional and emotional difficulties. The assumption that tics are limited to childhood is misleading, as a significant portion of adults continue to experience them. Effective management requires a combination of behavioral therapy, pharmacological support, and, in rare cases, neuromodulation. Most importantly, a multidisciplinary treatment plan and increased societal awareness play a crucial role in improving outcomes for individuals living with adult tic disorders.
References
-
Cavanna, A. E., & Rickards, H. (2013). The psychopathological spectrum of Gilles de la Tourette syndrome. Neuroscience & Biobehavioral Reviews, 37(6), 1008–1015.
-
Hirschtritt, M. E., Lee, P. C., Pauls, D. L., Dion, Y., Grados, M. A., Illmann, C., … & Mathews, C. A. (2015). Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry, 72(4), 325–333.
-
Kwak, C., Dat Vuong, K., & Jankovic, J. (2003). Premonitory sensory phenomena in Tourette’s syndrome. Movement Disorders, 18(12), 1530–1533.
-
Leckman, J. F., Bloch, M. H., Scahill, L., & King, R. A. (2013). Tourette disorder. Lancet, 362(9382), 210–219.
-
Martinez-Ramirez, D., Jimenez-Shahed, J., Leckman, J. F., Porta, M., Servello, D., Meng, F. G., … & Okun, M. S. (2018). Update on deep brain stimulation in Tourette syndrome. Translational Neurodegeneration, 7(1), 1–9.
-
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., … & Walkup, J. T. (2010). Behavior therapy for children with Tourette disorder: A randomized controlled trial. JAMA, 303(19), 1929–1937.
-
Robertson, M. M. (2015). A personal 35-year perspective on Gilles de la Tourette syndrome: Prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry, 2(1), 68–87.
-
Woods, D. W., Piacentini, J., Himle, M. B., & Chang, S. (2008). Premonitory urge for tics scale (PUTS): Initial psychometric results and examination of the premonitory urge phenomenon in youths with tic disorders. Journal of Developmental & Behavioral Pediatrics, 29(6), 458–468.